Our 2026 GEP Cohort:
Dr. Ahed Almalla, Dr. Christina Port, Dorit Cohen Carmon, Elena Pavlova, Francesca McDowell, Janina Stadter, Janna Hachmann, Jayanthi Narasimhan, Kimya Harris, Ph.D., Dr.Komali Valishetti, Marie Saxon, Rachel Rakvica Sprague, Simona Neubauer, MBA, Simone Sabbione, Sivan Sadan, Sophie Mina, Soumya Ramana, Dr. Tamasri Senapati, Yonat Harel-Preiss

A standout moment of the kick-off was our fireside chat with keynote speaker Christine Schuberth-Wagner. She brought exactly what this cohort needed: raw honesty, hard-won wisdom, and the kind of motivation that stays with you long after the room clears. The perfect tone-setter for what’s ahead.

And none of this happens without the incredible support of our sponsors. A special thank you to our Gold Sponsors Bayer Co.Lab (represented by Ruth R. Shah), Greenberg Traurig, LLP (represented by Emily Ladd-Kravitz), Kvalito Consulting Group and Berlin Institute of Health Clinical Incubator supported by BioLabs (represented by Garima Bhardwaj-Ohlendorf, Ph.D.) for believing in what we’re building. Closing the access and funding gap for early-stage founders in health and life sciences is a mission worth fighting for.

To the GEP 2026 cohort: the journey has begun. We cannot wait to see the impact you create.

The Global Entrepreneurial Leadership Program (GEP) is for those defined by their vision — CxOs & Founders in the healthcare & biopharma sector — who are driving innovation & navigating complex markets.

It is where executive leadership meets the agility of entrepreneurial thinking & where the human challenges –from personal resilience to board dynamics – matter if entrepreneurs are to lead as effectively as they innovate.​

It is about empowering women & allies to architect & lead new structures. GEP is about providing the strategic tools, the global network & the advanced mindset required to scale businesses & elevate impact worldwide.